Hesperos

company

About

Hesperos, Inc, is a leader in efforts to characterize an individual’s biology with human-on-a-chip microfluidic systems.

  • 11 - 50

Details

Last Funding Type
Grant
Industries
Biotechnology
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organ systems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.90M
Hesperos has raised a total of $1.90M in funding over 2 rounds. Their latest funding was raised on Aug 25, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 25, 2021 Grant $1.90M 1 National Institutes of Health Detail
Sep 27, 2019 Grant 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Hesperos is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant